HQL
abrdn Life Sciences Investors
NYSE · Financial Services · Asset Management · US
$17.03
+1.49%Latest reported
- Last report date
- Jun 24, 2025
- EPS actual
- -$1.64
- EPS estimate
- —
- Revenue actual
- $18.2M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jun 24, 2025 | — | -$1.64 | — | $18.2M |
| Dec 9, 2024 | — | $1.22 | — | $1.9M |
| Dec 11, 2023 | — | -$0.43 | — | $29.6M |
| Mar 31, 2023 | — | $1.29 | — | $1.9M |
| Sep 29, 2018 | — | $2.12 | — | $988.8K |
| Mar 31, 2018 | — | -$0.90 | — | $997.1K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jun 24, 2025